Improving compliance with cervical cancer screening guidelines.

about

Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females

P2860

Q36993972-7CF6AE98-90E8-4862-AB90-9B98CECA1F1B

P2860

Improving compliance with cervical cancer screening guidelines.

Item

http://www.wikidata.org/entity/Q36058295

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Improving compliance with cervical cancer screening guidelines.

@ast

Improving compliance with cervical cancer screening guidelines.

@en

type

Item

label

Improving compliance with cervical cancer screening guidelines.

@ast

Improving compliance with cervical cancer screening guidelines.

@en

prefLabel

Improving compliance with cervical cancer screening guidelines.

@ast

Improving compliance with cervical cancer screening guidelines.

@en

P1476

Improving compliance with cervical cancer screening guidelines

@en

P2093

Cara Goodell

http://www.w3.org/2001/XMLSchema#string

Eduardo Castro

http://www.w3.org/2001/XMLSchema#string

Hania Wehbe-Janek

http://www.w3.org/2001/XMLSchema#string

Jen Thomas

http://www.w3.org/2001/XMLSchema#string

Jessica Langsjoen

http://www.w3.org/2001/XMLSchema#string

Meghan Hinskey

http://www.w3.org/2001/XMLSchema#string

Thomas J Kuehl

http://www.w3.org/2001/XMLSchema#string

P2860

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

ACOG Practice Bulletin Number 131: Screening for cervical cancer.

Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.

Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer

The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Trade-offs in cervical cancer prevention: balancing benefits and risks.

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

P304

450-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08998280.2015.11929305

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26424938

http://www.w3.org/2001/XMLSchema#string

P932

4569221

http://www.w3.org/2001/XMLSchema#string

Improving compliance with cervical cancer screening guidelines.

about

P2860

P2860

Improving compliance with cervical cancer screening guidelines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932